T. Morisaki et al., IMMUNOSUPPRESSIVE CYTOKINES (IL-10, TGF-BETA) GENES EXPRESSION IN HUMAN GASTRIC-CARCINOMA TISSUES, Journal of surgical oncology, 63(4), 1996, pp. 234-239
Background: Contribution of immunosuppressive cytokines to tumor progr
ession in many types of cancers has been suggested. To characterize th
e in vivo expression of immunosuppressive cytokines in gastric cancer,
we analyzed the messenger RNA (mRNA) expression of transforming growt
h factor-beta (TGF-beta) and interleukin-10 (IL-10) in human gastric c
arcinoma tissues. Methods: Both tumor tissues and nontumor tissues fro
m each resected specimen of 29 primary gastric carcinomas were tested
for IL-10 and TGF-beta mRNA expression by the reverse transcriptase-po
lymerase chain reaction (RT-PCR), and the mRNA expression was correlat
ed with various pathological parameters of the tumors. Results: Among
the 29 tumors, mRNAs of TGF-beta and IL-10 were detected in 79% and 62
% of tumor samples, respectively. These cytokines were detected only i
n 31% for TGF-beta and 17% for IL-10 in nontumor samples. Both mRNAs w
ere frequently expressed in the poorly differentiated adenocarcinomas
and the tumor tissues with high degree of stage or lymphnode metastasi
s. Conclusions: Local expression of immunosuppressive cytokines may co
ntribute to the progression of primary gastric carcinomas possibly thr
ough immunosuppression. (C) 1996 Wiley-Liss, Inc.